TY  - JOUR
AU  - Alcaraz, Antonio
AU  - Castro-Díaz, David
AU  - Gacci, Mauro
AU  - Salonia, Andrea
AU  - Ficarra, Vincenzo
AU  - Carballido-Rodríguez, Joaquín
AU  - Rodríguez-Antolín, Alfredo
AU  - Medina-Polo, José
AU  - Fernández-Gómez, Jesús M
AU  - Cózar-Olmo, José M
AU  - Búcar-Terrades, Santiago
AU  - Pérez-León, Noemí
AU  - Brenes-Bermúdez, Francisco J
AU  - Molero-García, José M
AU  - Fernández-Pro-Ledesma, Antonio
AU  - Herdman, Michael
AU  - Angulo, Javier C
AU  - Manasanch, José
AU  - On Behalf Of The Qualiprost Study Group,
PY  - 2022
DO  - 10.3390/jcm11133615
SN  - 2077-0383
UR  - http://hdl.handle.net/10668/21303
T2  - Journal of clinical medicine
AB  - The objective of this subset analysis was to evaluate and compare the efficacy and tolerability of two combination treatments for men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH). Data...
LA  - en
KW  - 5-alpha-reductase inhibitors
KW  - BPH
KW  - combination therapy
KW  - hexanic extract of Serenoa repens
KW  - moderate-severe LUTS
KW  - prostate
KW  - quality of life
KW  - tamsulosin
KW  - urinary symptoms
TI  - Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study.
TY  - research article
VL  - 11
ER  -